Details of the Drug

General Information of Drug (ID: DMIHWTP)

Drug Name

PL-225B

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01779336) Clinical Study of Oral IGF-1R Inhibitor in Subjects With Advanced Refractory Solid Tumors. U.S. National Institutes of Health.